These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3201533)

  • 1. Phenytoin and phenobarbital assayed by the ACCULEVEL method compared with EMIT in an outpatient clinic setting.
    Morris RG; Schapel GJ
    Ther Drug Monit; 1988; 10(4):469-73. PubMed ID: 3201533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple and disposable visual measuring device to assay antiepileptic drugs from whole blood samples.
    Monaco F; Gianelli M; Dimanico U; Mutani R
    Ther Drug Monit; 1990 Jul; 12(4):359-61. PubMed ID: 2204151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of AccuLevel and TDx: evaluation of on-site monitoring of antiepileptic drugs.
    Nielsen IM; Gram L; Dam M
    Epilepsia; 1992; 33(3):558-63. PubMed ID: 1592037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenobarbital monitoring in whole blood with a quantitative noninstrumented test.
    Fairchild L; Wong E; Li TM; Litman DJ
    Ther Drug Monit; 1991 Sep; 13(5):425-7. PubMed ID: 1957335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid centrifugal analyzer enzyme immunoassays for phenytoin, phenobarbital, and primidone.
    Lacher DA; Sinn JA; Wills MR; Savory J
    Am J Clin Pathol; 1980 Aug; 74(2):205-8. PubMed ID: 6996473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a noninstrumented immunoassay for carbamazepine to high performance liquid chromatography and fluorescence polarization immunoassay.
    Cochran EB; Massey KL; Phelps SJ; Cramer JA; Toftness BR; Denio LS; Drake ME
    Epilepsia; 1990; 31(4):480-4. PubMed ID: 2369881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automation of the homogeneous substrate-labeled fluorescent immunoassay for theophylline in serum: application to the determination of phenytoin and phenobarbital in serum.
    Fingerhut B; Costanzo R; Chaudri Z; Rizvi S
    Ther Drug Monit; 1982; 4(4):419-25. PubMed ID: 6760476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Ames Seralyzer for the determination of carbamazepine, phenobarbital, and phenytoin concentrations in saliva.
    Miles MV; Tennison MB; Greenwood RS; Benoit SE; Thorn MD; Messenheimer JA; Ehle AL
    Ther Drug Monit; 1990 Sep; 12(5):501-10. PubMed ID: 2293415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Ames Seralyzer for the therapeutic drug monitoring of phenobarbital and phenytoin.
    Brettfeld C; Gobrogge R; Massoud N; Munzenberger P; Nigro M; Sarnaik A
    Ther Drug Monit; 1989 Sep; 11(5):612-5. PubMed ID: 2683255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of phenytoin and phenobarbital in serum or plasma by substrate-labeled fluorescent immunoassay.
    Dean KJ; Thompson SG; Burd JF; Buckler RT
    Clin Chem; 1983 Jun; 29(6):1051-6. PubMed ID: 6303626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochromatographic measurement of phenobarbital in whole blood with a non-instrumented assay.
    Wannamaker B; Denio L; Dodson WE; Dreifuss F; Crosby C; Santilli N; Duffner P; Ryan-Dudeck P; Conboy C; Ellis E
    Neurology; 1989 Sep; 39(9):1215-8. PubMed ID: 2671791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenytoin and phenobarbital concentrations in serum: a comparison of Ames Seralyzer with GLC, TDX, and EMIT.
    Leppik IE; Oles KS; Sheehan ML; Penry JK; Parker DR; Gallagher TK; Caron GP; Rosenfeld W; Salmon JJ
    Ther Drug Monit; 1989; 11(1):73-8. PubMed ID: 2643204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous quantitative assay of phenobarbital, phenytoin, and p-hydroxydiphenylhydantoin by HPLC and a comparison with EMIT.
    Couri D; Suarez del Villar C; Toy-Manning PT
    J Anal Toxicol; 1980; 4(5):227-31. PubMed ID: 7003258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effective assays for use in monitoring carbamazepine, phenobarbital, and phenytoin in serum.
    Moore FM; Simpson D
    Clin Chem; 1989 Aug; 35(8):1782-4. PubMed ID: 2503270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of saliva in therapeutic drug monitoring.
    Horning MG; Brown L; Nowlin J; Lertratanangkoon K; Kellaway P; Zion TE
    Clin Chem; 1977 Feb; 23(2 PT. 1):157-64. PubMed ID: 318941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme immunoassay, with use of a centrifugal analyzer, of phenytoin, phenobarbital, and theophylline.
    Long JP
    Clin Chem; 1978 Feb; 24(2):391. PubMed ID: 342139
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nephelometric inhibition immunoassay (NIIA), a new methodology for the determination of phenobarbital and phenytoin concentration in serum (author's transl)].
    Liappis N
    Klin Padiatr; 1982 Mar; 194(2):88-90. PubMed ID: 7047885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of diphenylhydantoin and phenobarbital by enzyme immunoassay and gas-liquid chromatography.
    Schmidt D
    J Neurol; 1976 Jul; 213(1):41-6. PubMed ID: 59797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain concentrations of phenytoin, phenobarbitone and primidone in epileptic patients.
    Houghton GW; Richens A; Toseland PA; Davidson S; Falconer
    Eur J Clin Pharmacol; 1975 Oct; 9(1):73-8. PubMed ID: 1233256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calibration, quality control, and stability of a quantitative enzyme immunochromatographic method for therapeutic drug monitoring.
    Opheim KE; Statland BE; Tillson SA; Litman DJ
    Ther Drug Monit; 1987 Jun; 9(2):190-6. PubMed ID: 3303468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.